AN2 Therapeutics Inc (ANTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.06
• Market Cap: $29.05M
• EPS: $-1.13
• 52-Week High: $1.55
• 52-Week Low: $1.00

Market Sentiment

AN2 Therapeutics Inc currently has a Bullish sentiment score of 0.22.

About AN2 Therapeutics Inc

ANTX, or AN2 Therapeutics Inc., is a pioneering biotechnology firm dedicated to advancing innovative therapies for rare and complex diseases, with a strong emphasis on immunology. Based in California, the company is committed to addressing critical unmet medical needs through its state-of-the-art research and development initiatives. AN2 is well-positioned for growth, underpinned by a promising pipeline of therapeutic candidates and strategic collaborations aimed at enhancing patient outcomes...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for AN2 Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ANTX pay dividends?

AN2 Therapeutics Inc (ANTX) does not currently pay a regular dividend.

What is ANTX's market cap?

AN2 Therapeutics Inc (ANTX) has a market capitalization of $29.05M with a current stock price of $1.06.